PIII P3 Health Partners Inc.

Nasdaq p3hp.org


$ 8.98 $ -0.19 (-2.15 %)    

Wednesday, 22-Oct-2025 09:02:34 EDT
QQQ $ 604.27 $ -5.89 (-0.96 %)
DIA $ 464.98 $ -3.44 (-0.73 %)
SPY $ 666.76 $ -3.49 (-0.52 %)
TLT $ 92.19 $ 0.06 (0.07 %)
GLD $ 376.01 $ 0.04 (0.01 %)
$ 8.7866
$ 8.72
$ 8.60 x 98
$ 9.50 x 2
$ 8.79 - $ 8.79
$ 5.80 - $ 24.73
513
na
63.15M
$ 1.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 10-21-2022 12-31-2021 10-K
14 10-21-2022 03-31-2022 10-Q
15 10-21-2022 06-30-2022 10-Q
16 11-18-2021 09-30-2021 10-Q
17 08-20-2021 06-30-2021 10-Q
18 05-25-2021 03-31-2021 10-Q
19 04-06-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 p3-health-partners-affirms-fy2025-sales-guidance-of-1350b-1500b-vs-1435b-est

P3 Health Partners (NASDAQ:PIII) affirms FY2025 sales outlook from $1.350 billion-$1.500 billion to $1.350 billion-$1.500 billi...

 p3-health-partners-q2-eps-623-misses-411-estimate-sales-355788m-miss-358223m-estimate

P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(6.23) per share which missed the analyst consensus estimate of ...

 p3-health-partners-affirms-fy2025-sales-guidance-of-135b-150b-vs-141b-est

P3 Health Partners (NASDAQ:PIII) affirms FY2025 sales outlook from $1.35 billion-$1.50 billion to $1.35 billion-$1.50 billion v...

 p3-health-partners-q1-eps-628-up-from-786-yoy-sales-37323m-beat-36207m-estimate

P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(6.28) per share. This is a 20.1 percent increase over losses of...

 lake-street-maintains-buy-on-p3-health-partners-lowers-price-target-to-20

Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from...

 medicare-advantage-rates-expected-to-climb-over-5-in-2026-easing-pressure-on-managed-care

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.

 p3-health-partners-q4-2024-gaap-eps-036-misses-009-estimate-sales-370686m-miss-378056m-estimate

P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of ...

 p3-health-targeting-profitability-in-2025-with-initial-revenue-guidance-for-the-year-of-1350b-15b-and-adjusted-ebitda-of-35m-5m

Company provides preliminary 2025 guidance and advance notification of a proposed financing transaction to provide a $30 millio...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION